Literature DB >> 9127009

Macrophage triggering with cecropin A and melittin-derived peptides induces type II nitric oxide synthase expression.

M Velasco1, M J Díaz-Guerra, P Díaz-Achirica, D Andreu, L Rivas, L Boscá.   

Abstract

Triggering of RAW 264.7 cells with a cecropin A-melittin hybrid peptide (CA(1-8)M(1-18)) promoted a rapid rise in the intracellular calcium concentration that was followed, after a lag period of 6 h, by nitric oxide synthesis through the expression of the cytokine-inducible form of nitric oxide synthase (type II NOS or iNOS). The maximal effect was obtained at peptide concentrations in the 2 to 5-microM range. Simultaneous incubation with the peptide and LPS abrogated the nitric oxide synthesis elicited after LPS treatment of the cells. CA(1-8)M(1-18) induced a rapid activation of nuclear factor kappaB as evidenced by the presence of p50/p65 heterodimers of the nuclear factor kappaB/c-Rel family in the nuclei of activated cells. This peptide also activated the reporter activity of cells transfected with a plasmid harboring a 1-kb fragment corresponding to the 5'-flanking region of the murine iNOS gene. CA(1-8)M(1-18) promoted apoptotic cell death at concentrations below 1 to 2 microM, whereas higher concentrations altered the plasma membrane integrity. These results suggest the involvement of multiple intracellular signaling pathways in the mechanism by which this peptide elicits macrophage triggering.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127009

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide.

Authors:  P Díaz-Achirica; J Ubach; A Guinea; D Andreu; L Rivas
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.

Authors:  S Hortelano; E López-Collazo; L Boscá
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis.

Authors:  J Alberola; A Rodríguez; O Francino; X Roura; L Rivas; D Andreu
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

4.  Design and activity of antimicrobial peptides against sporogonic-stage parasites causing murine malarias.

Authors:  Romanico B G Arrighi; Chikashi Nakamura; Jun Miyake; Hilary Hurd; J Grant Burgess
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

5.  The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system.

Authors:  Paula García-Huerta; Miguel Díaz-Hernandez; Esmerilda G Delicado; María Pimentel-Santillana; M Teresa Miras-Portugal; Rosa Gómez-Villafuertes
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

6.  Enhancement of Macrophage Function by the Antimicrobial Peptide Sublancin Protects Mice from Methicillin-Resistant Staphylococcus aureus.

Authors:  Shuai Wang; Qianhong Ye; Ke Wang; Xiangfang Zeng; Shuo Huang; Haitao Yu; Qing Ge; Desheng Qi; Shiyan Qiao
Journal:  J Immunol Res       Date:  2019-09-08       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.